| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |